8-(4-sulfophenyl)theophylline has been researched along with Cardiovascular Stroke in 32 studies
8-(4-sulfophenyl)theophylline: adenosine antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction." | 7.77 | Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. ( Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y, 2011) |
| " The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction." | 3.77 | Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. ( Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y, 2011) |
| "Adenosine concentration was significantly increased in IPC effluent (2." | 1.40 | Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation. ( Caldarone, CA; Callahan, J; Fu, YY; Kato, H; Leung, CH; Nielsen, JM; Redington, AN; Tropak, MB; Wang, L, 2014) |
| "Tyramine (Tyr) was intravenously administered before 30 min ischaemia in the absence or presence of bunazosin (BN, alpha1-receptor blocker) and staurosporine (ST), a protein kinase C inhibitor, respectively." | 1.33 | Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits. ( Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C, 2005) |
| "(3) Treatment with acadesine (2." | 1.29 | Acadesine extends the window of protection afforded by ischaemic preconditioning. ( Burckhartt, B; Cohen, MV; Downey, JM; Mullane, KM; Tsuchida, A; Yang, XM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (59.38) | 18.2507 |
| 2000's | 10 (31.25) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, CH | 1 |
| Wang, L | 1 |
| Nielsen, JM | 1 |
| Tropak, MB | 1 |
| Fu, YY | 1 |
| Kato, H | 1 |
| Callahan, J | 1 |
| Redington, AN | 1 |
| Caldarone, CA | 1 |
| Paiva, M | 1 |
| Riksen, NP | 1 |
| Davidson, SM | 1 |
| Hausenloy, DJ | 1 |
| Monteiro, P | 1 |
| Gonçalves, L | 1 |
| Providência, L | 1 |
| Rongen, GA | 1 |
| Smits, P | 1 |
| Mocanu, MM | 1 |
| Yellon, DM | 3 |
| Vessey, DA | 1 |
| Li, L | 1 |
| Honbo, N | 1 |
| Karliner, JS | 1 |
| Bai, Y | 1 |
| Murakami, H | 1 |
| Iwasa, M | 1 |
| Sumi, S | 1 |
| Yamada, Y | 1 |
| Ushikoshi, H | 1 |
| Aoyama, T | 1 |
| Nishigaki, K | 1 |
| Takemura, G | 2 |
| Uno, B | 1 |
| Minatoguchi, S | 2 |
| Darbera, L | 1 |
| Chenoune, M | 1 |
| Lidouren, F | 1 |
| Ghaleh, B | 1 |
| Cohen, MV | 7 |
| Downey, JM | 9 |
| Berdeaux, A | 1 |
| Tissier, R | 1 |
| Asanuma, H | 3 |
| Sanada, S | 2 |
| Ogai, A | 2 |
| Minamino, T | 4 |
| Takashima, S | 3 |
| Asakura, M | 1 |
| Ogita, H | 1 |
| Shinozaki, Y | 3 |
| Mori, H | 3 |
| Node, K | 3 |
| Tomoike, H | 2 |
| Hori, M | 3 |
| Kitakaze, M | 4 |
| Okuda, H | 1 |
| Fujita, M | 2 |
| Hirata, A | 2 |
| Kim, J | 2 |
| Asano, Y | 1 |
| Kitamura, S | 1 |
| Baba, K | 1 |
| Zhang, C | 1 |
| Kariya, T | 1 |
| Uno, Y | 1 |
| Kawai, T | 1 |
| Takahashi, M | 1 |
| Fujiwara, H | 1 |
| Kin, H | 1 |
| Zatta, AJ | 1 |
| Lofye, MT | 1 |
| Amerson, BS | 1 |
| Halkos, ME | 1 |
| Kerendi, F | 1 |
| Zhao, ZQ | 3 |
| Guyton, RA | 1 |
| Headrick, JP | 1 |
| Vinten-Johansen, J | 4 |
| Solenkova, NV | 1 |
| Solodushko, V | 1 |
| Wakeno, M | 1 |
| Seguchi, O | 1 |
| Okazaki, H | 1 |
| Tsukamoto, O | 1 |
| Okada, K | 1 |
| Komamura, K | 1 |
| Mochizuki, N | 1 |
| Armstrong, S | 1 |
| Ganote, CE | 1 |
| Bugge, E | 1 |
| Ytrehus, K | 1 |
| Williams, MW | 1 |
| Sato, H | 1 |
| Hudspeth, DA | 1 |
| McGee, DS | 2 |
| Van Wylen, DG | 1 |
| Woolfson, RG | 1 |
| Patel, VC | 2 |
| Neild, GH | 1 |
| Offstad, J | 1 |
| Kirkebøen, KA | 1 |
| Ilebekk, A | 2 |
| Downing, SE | 1 |
| Liu, GS | 2 |
| Richards, SC | 1 |
| Olsson, RA | 2 |
| Mullane, K | 1 |
| Walsh, RS | 3 |
| Tsuchida, A | 3 |
| Daly, JJ | 1 |
| Thornton, JD | 1 |
| Baxter, GF | 1 |
| Marber, MS | 1 |
| Nakanishi, K | 1 |
| Tan, P | 1 |
| Yang, XM | 2 |
| Burckhartt, B | 1 |
| Mullane, KM | 1 |
| Goto, M | 2 |
| Wang, P | 1 |
| Gallagher, KP | 1 |
| Funaya, H | 1 |
| Gysembergh, A | 1 |
| Margonari, H | 1 |
| Loufoua, J | 1 |
| Ovize, A | 1 |
| André-Fouët, X | 1 |
| Minaire, Y | 1 |
| Ovize, M | 1 |
| Miura, T | 2 |
| Kawamura, S | 1 |
| Sakamoto, J | 1 |
| Matsuzaki, M | 1 |
| Shimamoto, K | 1 |
| Grund, F | 1 |
| Sommerschild, HT | 1 |
| Lyberg, T | 1 |
| Kirkeboen, KA | 1 |
| Liem, DA | 2 |
| van den Doel, MA | 1 |
| de Zeeuw, S | 1 |
| Verdouw, PD | 2 |
| Duncker, DJ | 2 |
| Ploeg, H | 1 |
| Kazim, S | 1 |
| Toombs, CF | 1 |
| McGee, S | 1 |
| Johnston, WE | 1 |
| Thornton, J | 1 |
| Van Winkle, DM | 1 |
| Stanley, AW | 1 |
32 other studies available for 8-(4-sulfophenyl)theophylline and Cardiovascular Stroke
| Article | Year |
|---|---|
Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation.
Topics: Adenosine; Animals; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Mitochondria | 2014 |
Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.
Topics: Adenosine; Animals; Biological Transport; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; | 2009 |
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
Topics: Adenosine; Animals; Animals, Newborn; Cells, Cultured; In Vitro Techniques; Ischemic Preconditioning | 2009 |
Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
Topics: Adenosine; Animals; Cardiotonic Agents; Cilostazol; Decanoic Acids; Disease Models, Animal; Drug Eva | 2011 |
Adenosine and opioid receptors do not trigger the cardioprotective effect of mild hypothermia.
Topics: Adenosine; Analgesics, Opioid; Animals; Fluorocarbons; Hypothermia, Induced; Morphine; Myocardial In | 2012 |
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarctio | 2004 |
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
Topics: 5'-Nucleotidase; Adenosine Triphosphate; Androstadienes; Animals; Cardiotonic Agents; Chromones; Cor | 2004 |
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Rec | 2005 |
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine.
Topics: Adenosine; Animals; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Puri | 2005 |
Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.
Topics: Acetamides; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Androstadienes; An | 2006 |
Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.
Topics: 2-Chloroadenosine; Acetamides; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; An | 2006 |
Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
Topics: Adenosine; Animals; Antihypertensive Agents; Cells, Cultured; Glucose; Myocardial Infarction; Myocar | 1994 |
Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
Topics: Alkaloids; Animals; Benzophenanthridines; In Vitro Techniques; Male; Myocardial Infarction; Myocardi | 1995 |
Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Coronary Circulation; Extracellular Space; In Vitro | 1995 |
Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
Topics: Adenosine; Animals; Arginine; Lactates; Lactic Acid; Male; Myocardial Infarction; Myocardial Reperfu | 1995 |
ATP gated potassium channels in acute myocardial hibernation and reperfusion.
Topics: Adenosine Triphosphate; Animals; Glyburide; Ion Channel Gating; Myocardial Infarction; Myocardial Re | 1994 |
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
Topics: Adenosine; Animals; Antihypertensive Agents; Female; In Vitro Techniques; Male; Myocardial Infarctio | 1994 |
Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
Topics: Animals; Glyburide; Guanidines; Ketamine; Myocardial Infarction; Myocardial Ischemia; Myocardium; Pi | 1994 |
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
Topics: Adenosine; Animals; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardia | 1994 |
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Animals; Myocardial Infarction; Myocardial Ische | 1994 |
Acadesine extends the window of protection afforded by ischaemic preconditioning.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Female; Male; Myocardial Infarction; Myocardial Isch | 1994 |
Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release.
Topics: Adenosine; Adrenergic alpha-Antagonists; Animals; Catecholamines; Heart; Hemodynamics; Hypoxia; In V | 1995 |
Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.
Topics: Alkaloids; Animals; Benzophenanthridines; Coronary Vessels; Dioxoles; Endothelin Receptor Antagonist | 1996 |
Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cardiotonic Agents; Dipyridamole; Dogs; | 1997 |
Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon.
Topics: Animals; Coronary Disease; Electrocardiography; Hemodynamics; Injections, Intravenous; Ischemic Prec | 1997 |
Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart.
Topics: Animals; Coronary Circulation; Elasticity; Glyburide; Heart; Hematocrit; Hemodynamics; Ischemic Prec | 1998 |
Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
Topics: Animals; Cell Membrane; Cytosol; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Myoc | 1998 |
Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Embolism; Female; Ischemic Pr | 1999 |
Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors.
Topics: Acetamides; Adenosine; Analysis of Variance; Animals; Cryoprotective Agents; Dihydropyridines; Hista | 2001 |
Sites of action of adenosine in interorgan preconditioning of the heart.
Topics: Adenosine; Animals; Blood Pressure; Coronary Vessels; Ganglionic Blockers; Heart Rate; Hexamethonium | 2002 |
Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia.
Topics: Adenosine; Animals; Coronary Circulation; Coronary Disease; Heart; Hemodynamics; Male; Methods; Myoc | 1992 |
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.
Topics: Adenosine; Animals; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Purin | 1991 |